Finance

Lists
Q1 2027 earnings • released • EPS beat +50,01% • Revenue beat +7,03%
See results
NEOG:NASDAQ
Neogen Corp
11,85 US$
+1,20%
(+0,14) 1D
12,02 US$
+1,43% (+0,17)
After hours
Closed: 9 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NEOG...
Open
11,71 US$
High
12,11 US$
Low
11,57 US$
Mkt. cap
2,59 მლრდ.
Avg. vol.
4,43 მლნ.
Volume
3,65 მლნ.
52-wk high
14,18 US$
52-wk low
5,37 US$
EPS
-0,25 US$
Beta
1,79
Shares outstanding
218,31 მლნ.
No. of employees
3 ათ.
Open
11,71 US$
High
12,11 US$
Low
11,57 US$
Mkt. cap
2,59 მლრდ.
Avg. vol.
4,43 მლნ.
Volume
3,65 მლნ.
52-wk high
14,18 US$
52-wk low
5,37 US$
EPS
-0,25 US$
Beta
1,79
Shares outstanding
218,31 მლნ.
No. of employees
3 ათ.
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
6 საათის წინ
FDA Warning Letter Could Be A Game Changer For Neogen Stock (NEOG)
Investing.com
Investing.com
·
13 საათის წინ
Neogen CEO Mikheal Nassif buys $6,034 in stock
Investing.com Nigeria
Investing.com Nigeria
·
14 საათის წინ
Form 4 Neogen Corporation For: 9 October By Investing.com
Profile
Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan. The company serves a wide range of countries including Canada, United States, the United Kingdom, parts of Europe, Mexico and Brazil, India, and China, among others. The company operates a product line of over 100 drug detection test kits worldwide for the detection of about 300 abused and therapeutic drugs in animal treatment. In 2009, it became a vendor of the Chinese government and has been engaged in researching China-specific food safety and plant health issues. Wikipedia
About Neogen Corp
CEOჯონ ადენტ
Employees2,64 ათ.
Founded1982
Headquarters-
SectorMedical device
Websiteneogen.com
Analyst ratings
Based on 3 analysts giving stock ratings to NEOG in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NEOG in the last 3 months.
Highest
Current 11,85 US$
14,00 US$ (+18,14%)
Average
14,00 US$ (+18,14%)
Lowest
14,00 US$ (+18,14%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Westenberg
Piper Sandler
Buy
Maintained
14,00 US$
+18,1%
10/07/2026
Subbu Nambi
Guggenheim
Buy
Maintained
14,00 US$
+18,1%
09/29/2026
Brandon Vazquez
William Blair
Hold
Maintained
-
-
09/28/2026
Last report
6 ოქტ. 2026
Fiscal period
Q1 2027
0,08 US$ / 0,05 US$
+50,01%beat
Revenue / Est. (USD)
222,80 მლნ. / 208,18 მლნ.
+7,03%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ნოე. 2025
თებ. 2026
მაი. 2026
აგვ. 2026
Revenue
224,69 მლნ.
211,20 მლნ.
225,30 მლნ.
222,80 მლნ.
Cost of goods sold
118,01 მლნ.
112,20 მლნ.
117,50 მლნ.
117,30 მლნ.
Cost of revenue
118,01 მლნ.
112,20 მლნ.
117,50 მლნ.
117,30 მლნ.
Research and development expenses
4,56 მლნ.
3,80 მლნ.
4,90 მლნ.
6,50 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
107,50 მლნ.
98,50 მლნ.
99,80 მლნ.
100,80 მლნ.
Operating expense
112,06 მლნ.
102,30 მლნ.
104,70 მლნ.
107,30 მლნ.
Total operating expenses
230,07 მლნ.
214,50 მლნ.
222,20 მლნ.
224,60 მლნ.
Operating income
-5,38 მლნ.
-3,30 მლნ.
3,10 მლნ.
-1,80 მლნ.
Other non operating income
-477,00 ათ.
-3,10 მლნ.
4,50 მლნ.
1,10 მლნ.
EBT including unusual items
-20,36 მლნ.
-20,30 მლნ.
-12,10 მლნ.
-14,90 მლნ.
EBT excluding unusual items
-20,36 მლნ.
-20,30 მლნ.
-12,10 მლნ.
-14,50 მლნ.
Income tax expense
-4,44 მლნ.
-3,30 მლნ.
-800,00 ათ.
-3,00 მლნ.
Effective tax rate
21,80%
16,26%
6,61%
20,13%
Other operating expenses
-
-
-
-
Net income
-15,92 მლნ.
-17,00 მლნ.
-11,30 მლნ.
-11,90 მლნ.
Net profit margin
-7,09%
-8,05%
-5,02%
-5,34%
Earnings per share
0,10
0,09
0,09
0,08
Interest and investment income
592,00 ათ.
-
-
-
Interest expense
-14,85 მლნ.
-13,90 მლნ.
-13,90 მლნ.
-13,80 მლნ.
Net interest expenses
-14,26 მლნ.
-13,90 მლნ.
-13,90 მლნ.
-13,80 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
23,55 მლნ.
25,62 მლნ.
32,50 მლნ.
27,30 მლნ.
Gain or loss from assets sale
267,00 ათ.
224,00 ათ.
-
500,00 ათ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები